Literature DB >> 21629973

Severe systemic reaction to topical imiquimod.

Anna-Kaisa Heikkinen, Päivikki Susitaival.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21629973     DOI: 10.2340/00015555-1121

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  6 in total

1.  Tolerability and Pharmacokinetics of Ingenol Mebutate 0.05% Gel Applied to Treatment Areas up to 100cm(2) on the Forearm(s) of Patients with Actinic Keratosis.

Authors:  Lawrence Anderson; Michael Jarratt; George Schmieder; Stephen Shumack; Janelle Katsamas; Peter Welburn
Journal:  J Clin Aesthet Dermatol       Date:  2014-12

2.  Topical imiquimod-induced linear IgA bullous dermatosis.

Authors:  Giulia Tadiotto Cicogna; Martina Ferranti; Daniele Vaccari; Mauro Alaibac
Journal:  BMJ Case Rep       Date:  2019-07-19

3.  An Investigator-initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses on Dorsal Hands and Forearms.

Authors:  Gary Goldenberg; Rita V Linkner; Giselle Singer; Amylynne Frankel
Journal:  J Clin Aesthet Dermatol       Date:  2013-02

4.  Make It Simple: (SR-A1+TLR7) Macrophage Targeted NANOarchaeosomes.

Authors:  Federico Leonel Parra; Ayelen Tatiana Caimi; Maria Julia Altube; Diego Esteban Cargnelutti; Mónica Elba Vermeulen; Marcelo Alexandre de Farias; Rodrigo Villares Portugal; Maria Jose Morilla; Eder Lilia Romero
Journal:  Front Bioeng Biotechnol       Date:  2018-11-06

5.  Local skin reactions and the onset of influenza-like signs and symptoms induced by imiquimod.

Authors:  Neal Bhatia
Journal:  JAAD Int       Date:  2022-03-30

Review 6.  Acantholytic pityriasis rubra pilaris associated with topical use of imiquimod 5%: case report and literature review.

Authors:  Oriete Gerin Leite; Sandra Tagliolatto; Elemir Macedo de Souza; Maria Letícia Cintra
Journal:  An Bras Dermatol       Date:  2019-11-23       Impact factor: 1.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.